These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35690691)

  • 1. Hemodynamic consequences of respiratory interventions in preterm infants.
    Sehgal A; Ruoss JL; Stanford AH; Lakshminrusimha S; McNamara PJ
    J Perinatol; 2022 Sep; 42(9):1153-1160. PubMed ID: 35690691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome.
    Fujii A; Allen R; Doros G; O'Brien S
    J Perinatol; 2010 Oct; 30(10):671-6. PubMed ID: 20336077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous distending pressure for respiratory distress in preterm infants.
    Ho JJ; Subramaniam P; Davis PG
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD002271. PubMed ID: 26141572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of synchronized intermittent mandatory ventilation versus pressure support plus volume guarantee ventilation in the weaning phase of preterm infants*.
    Erdemir A; Kahramaner Z; Turkoglu E; Cosar H; Sutcuoglu S; Ozer EA
    Pediatr Crit Care Med; 2014 Mar; 15(3):236-41. PubMed ID: 24608494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous positive airway pressure (CPAP) for respiratory distress in preterm infants.
    Ho JJ; Subramaniam P; Davis PG
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD002271. PubMed ID: 33058208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.
    Engle WA;
    Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot observational study on haemodynamic changes after surfactant administration in preterm newborns with respiratory distress syndrome.
    Vitali F; Galletti S; Aceti A; Aquilano G; Fabi M; Balducci A; Faldella G
    Ital J Pediatr; 2014 Mar; 40(1):26. PubMed ID: 24594243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical characteristics and cardiac hemodynamic changes of patent ductus ateriosus in preterm infants].
    Lu D; Liu Y; Tong X
    Zhonghua Er Ke Za Zhi; 2015 Mar; 53(3):187-93. PubMed ID: 26165015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome.
    Fujii AM; Patel SM; Allen R; Doros G; Guo CY; Testa S
    J Perinatol; 2010 Oct; 30(10):665-70. PubMed ID: 20336076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The short-term outcome of a large cohort of very preterm infants treated with poractant alfa (Curosurf) for respiratory distress syndrome. A postmarketing phase IV study.
    Lamboley-Gilmert G; Lacaze-Masmonteil T;
    Paediatr Drugs; 2003; 5(9):639-45. PubMed ID: 12956620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant therapy for respiratory distress syndrome in premature neonates: a comparative review.
    Ainsworth SB; Milligan DW
    Am J Respir Med; 2002; 1(6):417-33. PubMed ID: 14720029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid improvement of static compliance after surfactant treatment in preterm infants with respiratory distress syndrome.
    Baraldi E; Pettenazzo A; Filippone M; Magagnin GP; Saia OS; Zacchello F
    Pediatr Pulmonol; 1993 Mar; 15(3):157-62. PubMed ID: 8327278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RDS--CPAP or surfactant or both.
    Bohlin K
    Acta Paediatr; 2012 Apr; 101(464):24-8. PubMed ID: 22404888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy analysis of different pulmonary surfactants in premature infants with respiratory distress syndrome].
    Xu H; Xu P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):174-179. PubMed ID: 33729136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal intermittent positive pressure ventilation versus nasal continuous positive airway pressure for preterm infants with respiratory distress syndrome: a meta-analysis and up-date.
    Li W; Long C; Zhangxue H; Jinning Z; Shifang T; Juan M; Renjun L; Yuan S
    Pediatr Pulmonol; 2015 Apr; 50(4):402-9. PubMed ID: 25418007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal continuous positive airway pressure versus nasal intermittent positive-pressure ventilation within the minimally invasive surfactant therapy approach in preterm infants: a randomised controlled trial.
    Oncel MY; Arayici S; Uras N; Alyamac-Dizdar E; Sari FN; Karahan S; Canpolat FE; Oguz SS; Dilmen U
    Arch Dis Child Fetal Neonatal Ed; 2016 Jul; 101(4):F323-8. PubMed ID: 26553376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in respiratory management of transferred very preterm infants in the last two decades.
    Cavallin F; Doglioni N; Brombin L; Lolli E; Loddo C; Cavicchiolo ME; Mardegan V; Magarotto M; Mainini N; Nardo D; Peloso RL; Piva D; Priante E; Valerio E; Baraldi E; Trevisanuto D
    Pediatr Pulmonol; 2021 Aug; 56(8):2604-2610. PubMed ID: 34171179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surfactant treatment of premature infants with respiratory distress syndrome].
    Lindemann R; Grøgaard J
    Tidsskr Nor Laegeforen; 1991 Mar; 111(8):1032-3. PubMed ID: 2042202
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemodynamic Effects of Nasal Intermittent Positive Pressure Ventilation in Preterm Infants.
    Chang HY; Cheng KS; Lung HL; Li ST; Lin CY; Lee HC; Lee CH; Hung HF
    Medicine (Baltimore); 2016 Feb; 95(6):e2780. PubMed ID: 26871833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.